Yeah I know. I like him. He definately knows what he is doing. I know, I think MS will be a big blowout year for BIIB. I'm really excited to see how BG-12's launch trajectory looks like.
On GSK's breakout at JPM, I was surprised to hear that they are planning to do nothing new to marketing strategy for Benlysta. Oh well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.